Loading…
Based on limited metadata, Optikem International Inc., a pharmaceutical company, received an FDA Warning Letter on June 20, 2024, regarding drug products. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning relates to FDA drug regulation and enforcement, though the specific issuing office and violation count are not documented in the metadata provided.